Valemetostat Pivotal Data Shows Promising Response Rates in Patients with Adult T-Cell Leukemia/Lymphoma
Oral presentation at ASH 2021 features positive phase 2 data in Japanese patients with relapsed/refractory…
Oral presentation at ASH 2021 features positive phase 2 data in Japanese patients with relapsed/refractory…
Follow-up results from Phase 2 trial suggested intolerable adverse events leading to discontinuation of previous…
LITTLETON, Colo.--(BUSINESS WIRE)--Rare Element Resources Ltd. (the “Company” or “RER”) (OTCQB: REEMF) is pleased to…
ZUG, SWITZERLAND - EQS Newswire - 11 December 2021 - SunMirror AG ("SunMirror", "the Company"; Vienna…
DAYTONA BEACH, Fla., Dec. 10, 2021 (GLOBE NEWSWIRE) -- CTO Realty Growth, Inc. (NYSE: CTO)…
Pony.ai now has autonomous driving public road testing permits in all four Tier-1 cities in…
DUBLIN--(BUSINESS WIRE)--The "Semiconductor Intellectual Property Global Market Report 2021: COVID-19 Growth and Change" report has…
DUBLIN--(BUSINESS WIRE)--The "Semiconductor Intellectual Property Global Market Report 2021: COVID-19 Growth and Change" report has…
DUBLIN--(BUSINESS WIRE)--The "Global & Asia Pacific High Throughput Screening Market Outlook 2030" report has been…
The shareholders of Karolinska Development AB (publ), reg. no. 556707-5048, (“Karolinska Development” or the “Company”)…